KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Goodwill & Intangibles: 2009-2011

Historic Goodwill & Intangibles for Alnylam Pharmaceuticals (ALNY) over the last 3 years, with Dec 2011 value amounting to $275,000.

  • Alnylam Pharmaceuticals' Goodwill & Intangibles fell 54.40% to $145,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $145,000, marking a year-over-year decrease of 54.40%. This contributed to the annual value of $275,000 for FY2011, which is 38.62% down from last year.
  • Alnylam Pharmaceuticals' Goodwill & Intangibles amounted to $275,000 in FY2011, which was down 38.62% from $448,000 recorded in FY2010.
  • Alnylam Pharmaceuticals' Goodwill & Intangibles' 5-year high stood at $867,659 during FY2009, with a 5-year trough of $275,000 in FY2011.
  • Its 3-year average for Goodwill & Intangibles is $530,220, with a median of $448,000 in 2010.
  • Data for Alnylam Pharmaceuticals' Goodwill & Intangibles shows a maximum YoY crashed of 48.37% (in 2010) over the last 5 years.
  • Yearly analysis of 3 years shows Alnylam Pharmaceuticals' Goodwill & Intangibles stood at $867,659 in 2009, then tumbled by 48.37% to $448,000 in 2010, then slumped by 38.62% to $275,000 in 2011.